Abstract:Chronic or intermittent hyperglycemia is associated with the development of diabetic complications. Several signaling pathways can be altered by having hyperglycemia in different tissues, producing oxidative stress, the formation of advanced glycation end products (AGEs), as well as the secretion of the pro-inflammatory cytokines and cellular death (pathological autophagy and/or apoptosis). However, the signaling pathways that are directly triggered by hyperglycemia appear to have a pivotal role in diabetic complications due to the production of reactive oxygen species (ROS), oxidative stress, and cellular death. The present review will discuss the role of cellular death in diabetic complications, and it will suggest the cause and the consequences between the hyperglycemia-induced signaling pathways and cell death. The signaling pathways discussed in this review are to be described step-by-step, together with their respective inhibitors. They involve diacylglycerol, the activation of protein kinase C (PKC) and NADPH-oxidase system, and the consequent production of ROS. This was initially entitled the “dangerous metabolic route in diabetes”. The historical usages and the recent advancement of new drugs in controlling possible therapeutical targets have been highlighted, in order to evaluate the evolution of knowledge in this sensitive area. It has recently been shown that the metabolic responses to stimuli (i.e., hyperglycemia) involve an integrated network of signaling pathways, in order to define the exact responses. Certain new drugs have been experimentally tested—or suggested and proposed—for their ability to modulate the possible biochemical therapeutical targets for the downregulation of retinopathy, nephropathy, neuropathy, heart disease, angiogenesis, oxidative stress, and cellular death. The aim of this study was to critically and didactically evaluate the exact steps of these signaling pathways and hence mark the indicated sites for the actions of such drugs and their possible consequences. This review will emphasize, besides others, the therapeutical targets for controlling the signaling pathways, when aimed at the downregulation of ROS generation, oxidative stress, and, consequently, cellular death—with all of these conditions being a problem in diabetes.

Review on Abnormal Apoptosis and Pathological Changes of Histiocyte Initiated by Diabetes Mellitus

C/EBP Homologous Protein Induces Mesangial Cell Apoptosis under Hyperglycemia

The Apoptotic Pathways and Their Mechanisms

Acetylcholinesterase is Associated with Apoptosis in Β Cells and Contributes to Insulin-Dependent Diabetes Mellitus Pathogenesis

Mitochondrial Apoptosis of Lymphocyte is Induced in Type 2 Diabetes

The relationship between HMGB1 and autophagy in the pathogenesis of diabetes and its complications

Research Progress on the Mechanism of Beta-Cell Apoptosis in Type 2 Diabetes Mellitus

Cellular death, reactive oxygen species (ROS) and diabetic complications

Pancreatic β‐cell apoptosis in type 2 diabetes is related to post‐translational modifications of p53 (Review)

Cell Proliferation and Apoptosis in Diabetic Dermal Tissues

Clinical pathophysiology of diabetic microangiopathy

High glucose and interleukin 1β-induced apoptosis in human umbilical vein endothelial cells involves in down-regulation of monocarboxylate transporter 4

High Glucose Alters Apoptosis and Proliferation in HEK293 Cells by Inhibition of Cloned BKCa Channel

Calcium entry mediates hyperglycemia-induced apoptosis through Ca(2+)/calmodulin-dependent kinase II in retinal capillary endothelial cells.

High Glucose Induces Apoptosis in Embryonic Neural Progenitor Cells by a Pathway Involving Protein PKCδ

Potential Molecular Mechanisms and Therapeutic Targets

Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy

The interregulatory circuit between non-coding RNA and apoptotic signaling in diabetic cardiomyopathy

Accelerated Senescence and Apoptosis in the Rat Liver during the Progression of Diabetic Complications

Hyperglycemia-induced myocardial fibrosis may be associated with pyroptosis and apoptosis of cardiomyoctes in diabetic mice

Pathophysiological changes of dermal tissue in diabetic rats and their mechanisms